Concepedia

Matthew Bedford

MB

6

Publications

321

Citations

6

H-Index

2012

Active since

Affiliations

University of Birmingham(Current)

University Hospitals Birmingham NHS Foundation Trust

University of Bristol

Matthew Bedford is an author at University of Birmingham specializing in colorectal cancer, medicine, and oncology.

Top concepts

MedicineOncologyColorectal CancerSurgeryChemistryPathologyEngineeringCell BiologyPharmacologyHealth Policy

Publications per year

2012–2022

6

Publications

6

Deferasirox (<scp>ICL670A</scp>) effectively inhibits oesophageal cancer growth <i>in vitro</i> and <i>in vivo</i>

Peyman Obeidy, DB Lovejoy, Matthew Bedford et al. · British Journal of Pharmacology · 2012 · 81 citations

The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma

Jiaxin Wen, Matthew Bedford, Ruksana Begum et al. · Journal of Surgical Oncology · 2018 · 72 citations

BRAF mutations are associated with increased iron regulatory protein‐2 expression in colorectal tumorigenesis

Richard D. Horniblow, Matthew Bedford, Robert M. Hollingworth et al. · Cancer Science · 2017 · 63 citations · Full text

Iron Metabolism, Colorectal Tumorigenesis, Pathology +16

Organometallic Nucleoside Analogues with Ferrocenyl Linker Groups: Synthesis and Cancer Cell Line Studies

Huy V. Nguyen, Antoine Sallustrau, Jan Balzarini et al. · Journal of Medicinal Chemistry · 2014 · 46 citations · Full text

Chiral Ferrocene Derivatives, Medicinal Chemistry, Organometallic Compounds +15

Delivery of drinking, eating and mobilising (DrEaMing) and its association with length of hospital stay after major noncardiac surgery: observational cohort study

Charles Matthew Oliver, Samantha Warnakulasuriya, Dermot McGuckin et al. · British Journal of Anaesthesia · 2022 · 38 citations · Full text

Rows per page

1–5 of 6